%0 Journal Article
%A Font, Carme
%A Carmona-Bayonas, Alberto
%A Beato, Carmen
%A Reig, Oscar
%A Saez, Antonia
%A Jimenez-Fonseca, Paula
%A Plasencia, Juana M.
%A Calvo-Temprano, David
%A Sanchez, Marcelo
%A Benegas, Mariana
%A Biosca, Mercedes
%A Varona, Diego
%A Angeles-Vicente, Maria
%A Faez, Laura
%A del-Pilar-Solis, Maria
%A de-la-Haba, Irma
%A Antonio, Maite
%A Madridano, Olga
%A Castanon, Eduardo
%A Martinez, Maria Jose 
%A Marchena, Pablo
%A Ramchandani, Avinash
%A Dominguez, Angel
%A Puerta, Alejandro
%A Martinez-de-la-Haza, David
%A Pueyo, Jesus
%A Hernandez, Susana
%A Fernandez-Plaza, Angela
%A Martinez-Encarnacion, Lourdes
%A Martin, Mar
%A Marin, Gema
%A Ayala, Francisco
%A Vicente, Vicente
%A Otero, Remedios
%T Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study
%D 2017
%@ 0903-1936
%U http://hdl.handle.net/10668/19113
%X The study aimed to identify predictors of overall 30-day mortality in cancer patients with pulmonary embolism including suspected pulmonary embolism (SPE) and unsuspected pulmonary embolism (UPE) events. Secondary outcomes included 30-and 90-day major bleeding and venous thromboembolism (VTE) recurrence.The study cohort included 1033 consecutive patients with pulmonary embolism from the multicentre observational ambispective EPIPHANY study (March 2006-October 2014). A subgroup of 497 patients prospectively assessed for the study were subclassified into three work-up scenarios (SPE, truly asymptomatic UPE and UPE with symptoms) to assess outcomes.The overall 30-day mortality rate was 14%. The following variables were associated with the overall 30day mortality on multivariate analysis: VTE history, upper gastrointestinal cancers, metastatic disease, cancer progression, performance status, arterial hypotension 110 beats.min(-1), basal oxygen saturation
%K Adversely impact survival
%K Venous thromboembolism
%K Outpatient management
%K Prognostic model
%K Severity index
%K Risk
%K Guidelines
%K Diagnosis
%~